Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lieto

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 15, 2001
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicatorF De Vita, C Romano, M Orditura, et al.
Chest|February 12, 2000
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patientsF De Vita, M Orditura, G Galizia, et al.
Chirurgia Italiana|January 1, 1997
[Multidisciplinary treatment of hepatocarcinoma]G Galizia, E Lieto, P Castellano, et al.
Surgical Endoscopy|May 17, 2001
Hemodynamic and pulmonary changes during open, carbon dioxide pneumoperitoneum and abdominal wall-lifting cholecystectomy. A prospective, randomized studyG Galizia, G Prizio, E Lieto, et al.
Oncology Reports|February 15, 2000
Serum interleukin-10 is an independent prognostic factor in advanced solid tumorsF De Vita, M Orditura, G Galizia, et al.
Cancer|November 26, 1999
Serum interleukin-10 levels in patients with advanced gastrointestinal malignanciesF De Vita, M Orditura, G Galizia, et al.
Oncogene|May 29, 2007
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancerG Galizia, E Lieto, F De Vita, et al.
Cancer Immunology, Immunotherapy : CII|December 29, 2000
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survivalM Orditura, C Romano, F De Vita, et al.
Nature Biotechnology|January 3, 2001
Counting alleles reveals a connection between chromosome 18q loss and vascular invasionW Zhou, G Galizia, E Lieto, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 19, 2011
Complete response to preoperative chemoradiation and survival in esophageal cancer: a pooled analysis of three single-institution phase II trialsM Orditura, G Galizia, F Morgillo, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 15, 2001
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicatorF De Vita, C Romano, M Orditura, et al.
Chest|February 12, 2000
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patientsF De Vita, M Orditura, G Galizia, et al.
Chirurgia Italiana|January 1, 1997
[Multidisciplinary treatment of hepatocarcinoma]G Galizia, E Lieto, P Castellano, et al.
Surgical Endoscopy|May 17, 2001
Hemodynamic and pulmonary changes during open, carbon dioxide pneumoperitoneum and abdominal wall-lifting cholecystectomy. A prospective, randomized studyG Galizia, G Prizio, E Lieto, et al.
Oncology Reports|February 15, 2000
Serum interleukin-10 is an independent prognostic factor in advanced solid tumorsF De Vita, M Orditura, G Galizia, et al.
Cancer|November 26, 1999
Serum interleukin-10 levels in patients with advanced gastrointestinal malignanciesF De Vita, M Orditura, G Galizia, et al.
Oncogene|May 29, 2007
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancerG Galizia, E Lieto, F De Vita, et al.
Cancer Immunology, Immunotherapy : CII|December 29, 2000
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survivalM Orditura, C Romano, F De Vita, et al.
Nature Biotechnology|January 3, 2001
Counting alleles reveals a connection between chromosome 18q loss and vascular invasionW Zhou, G Galizia, E Lieto, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 19, 2011
Complete response to preoperative chemoradiation and survival in esophageal cancer: a pooled analysis of three single-institution phase II trialsM Orditura, G Galizia, F Morgillo, et al.
Pageof 3